Figure 2. A, expression patterns of CeTRAP240-
let-19. A reporter construct containing a 2.0-kilobase fragment encompassing the CeTRAP240-
let-19 promoter and regulatory region-driving expression of GFP was injected into N2 hermaphrodites. Expression was monitored in different stages, tissues and cells: a, 200-cell stage embryo; b, vulva (arrow); c, neurons in tail, hypodermal cell (arrow), and skeletal muscle (yellow arrow); d, H-shaped excretory canal (arrow). B, CeTRAP240-
let-19(RNAi) phenotypes. Depending on dosage of dsRNA, disruption of CeTRAP240-
let-19 function by RNAi resulted in substantial embryonic lethality; survivors developed several phenotypes: a, embryonic arrest at 200-300 cell stage; b, abnormal head morphology; c, abnormal tail morphology; d, withered tail and cuticle shedding defect; e, multivulva. C, the C terminus of CeTRAP240/LET-19 is an intrinsic transcriptional repressor. A549 cells were transfected with various amounts of expression plasmids, as indicated, that encode either GAL4 DNA binding domain, GAL4-LET-19-C, or GAL4-TLE1 together with a (GAL4)5E1BLuc reporter (150 ng). The RSV-LacZ plasmid was also transfected to normalize transfection efficiency. Results shown here are representative of three independent experiments.